Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Fish and Richardson
Harvard Business School
Covington
Fuji
Cantor Fitzgerald
AstraZeneca
Citi
Novartis

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,834,849

« Back to Dashboard

Which drugs does patent 8,834,849 protect, and when does it expire?

Patent 8,834,849 protects PROAIR HFA and is included in one NDA.

This patent has sixteen patent family members in thirteen countries.
Summary for Patent: 8,834,849
Title:Medicinal aerosols and methods of delivery thereof
Abstract: The replacement of chlorofluorohydrocarbon propellants in medical aerosols is of the utmost importance to the pharmaceutical industry. A number of formulations have been investigated. The present invention provides a medical aerosol formulation comprising a particular medicament, a fluorocarbon propellant and 6 to 25% w/w of the total formulation of a polar co-solvent, such formulation being substantially free of surfactant. Canisters suitable for delivering such a pharmaceutical formulation are also provided.
Inventor(s): Millar; Fiona Catherine (Waterford, IE)
Assignee: Norton Healthcare Limited (London, GB)
Application Number:12/455,236
Patent Claim Types:
see list of patent claims
Formulation; Delivery;

Drugs Protected by US Patent 8,834,849

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Teva Branded Pharm PROAIR HFA albuterol sulfate AEROSOL, METERED;INHALATION 021457-001 Oct 29, 2004 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,834,849

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9616237.5Aug 1, 1996

Non-Orange Book US Patents Family Members for Patent 8,834,849

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,566,445 Medicinal aerosols and methods of delivery thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,834,849

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 325491 ➤ Subscribe
Norway 990454 ➤ Subscribe
Japan 2011173910 ➤ Subscribe
Japan 4794701 ➤ Subscribe
Japan 2000515536 ➤ Subscribe
United Kingdom 9616237 ➤ Subscribe
Spain 2175413 ➤ Subscribe
European Patent Office 0918507 ➤ Subscribe
Denmark 0918507 ➤ Subscribe
Germany 69711637 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
Healthtrust
Novartis
Fish and Richardson
Colorcon
Moodys
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot